ALGN Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

Total Revenues: $1.04 billion, up 6.2% year-over-year.
Clear Aligner Revenue: $856 million, a 7.4% increase year-over-year.
Clear Aligner Shipments: 686,000 cases, up 6.7% year-over-year.
Gross Margin: 70.8%, up 1.4 points year-over-year; non-GAAP gross margin at 71.8%.
Operating Income: $142 million, with an operating margin of 13.6%.
Net Income per Diluted Share: $1.57, up from $1.26 year-over-year; non-GAAP EPS at $2.58, up 21%.
Cash Flow from Operations: $151 million; free cash flow of $120.3 million.
Cash and Cash Equivalents: $1.06 billion, up $186.8 million year-over-year.

2. Strategic Updates and Business Highlights:

Strong demand for Clear Aligners, particularly in international markets (double-digit growth in EMEA, APAC, and Latin America).
Continued adoption of digital platforms, including the iTero scanner and Invisalign products, with over 12 million scans performed in Q1.
Launch of the Invisalign Advanced Restorative Treatment pilot in the U.S. to integrate orthodontics with restorative dentistry.
Growth in the Doctor Subscription Program (DSP) and patient financing initiatives, enhancing affordability and treatment conversion.
Expansion of peer-to-peer mentoring programs to boost clinical confidence among practitioners.

3. Forward Guidance and Outlook:

Q2 2026 Revenue Guidance: Expected to be between $1.040 billion and $1.060 billion, reflecting a 3% to 5% year-over-year increase.
2026 Full-Year Revenue Growth: Expected to be 3% to 4% year-over-year, with mid-single-digit growth in Clear Aligner volumes.
Operating Margin Guidance: GAAP operating margin around 16.4% and non-GAAP operating margin approximately 21.5% for Q2; full-year non-GAAP margin expected at 23.7%.
Plans to repurchase an additional $200 million of common stock over the next six months.

4. Bad News, Challenges, or Points of Concern:

Geopolitical Risks: Ongoing military action in the Middle East may impact patient traffic and consumer demand, particularly in EMEA, although the first quarter's impact was deemed immaterial.
North American Market Weakness: Decline in North American case growth, attributed to macroeconomic factors and competition, contrasting with strong international performance.
Operating Expenses: Increased by 8.3% year-over-year due to legal settlements and higher employee compensation, raising concerns about cost management.
ASP Trends: Average selling prices are expected to decline by 1% to 2% for the year due to product and country mix shifts.

5. Notable Q&A Insights:

Management confirmed that the Middle East market contributes in the single digits to overall revenue, with minimal disruption noted in production and shipments.
The DSO channel continues to drive growth, while retail channels face challenges, particularly in the U.S.
The rollout of the Zero AA product is progressing, but adoption rates are gradual, with no significant revenue contributions expected in 2026.
Concerns regarding resin costs were addressed, with management indicating that about 25% of COGS is related to resin, but they feel protected against significant inflationary impacts.
The company is maintaining a cautious outlook due to macroeconomic uncertainties while focusing on strategic investments and operational efficiencies.

ALGN — Align Technology, Inc.